Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through

Pascal Richette1, Marie-France Dumontier, Khadija Tahiri

  • 1INSERM UMR-747, Universite Paris Descartes, UFR Biomedicale, Paris, France.

Abstract

Insights

Oestrogen receptor alpha (ERalpha) in chondrocytes inhibits interleukin-1beta-induced nitric oxide production. This occurs by reducing inducible nitric oxide synthase (iNOS) gene expression via decreased NF-kappaB p65 DNA binding and nuclear translocation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Interleukin-1beta (IL-1beta) is a pro-inflammatory cytokine implicated in cartilage degradation.
  • Oestrogen receptors, particularly oestrogen receptor alpha (ERalpha), play roles in various cellular processes.
  • The interaction between oestrogens and inflammatory pathways in chondrocytes is not fully understood.

Purpose of the Study:

  • To investigate ERalpha presence and function in IL-1beta-treated rabbit articular chondrocytes.
  • To elucidate the mechanisms by which 17beta-oestradiol (E2) affects IL-1beta-induced inducible nitric oxide synthase (iNOS) expression.

Main Methods:

  • Immunocytochemistry and reporter gene assays for ERalpha functionality.
  • Reporter gene assays and immunoblotting for iNOS expression and production.
  • Griess reaction for nitric oxide (NO) production.
  • Electrophoretic mobility shift assay (EMSA)-ELISA for transcription factor DNA-binding.
  • Immunocytochemistry for p65 nuclear translocation.

Main Results:

  • ERalpha was identified in chondrocyte nuclei and was functional.
  • IL-1beta treatment caused partial ERalpha cytoplasmic diffusion and impaired transactivation.
  • E2, tamoxifen, and raloxifene inhibited IL-1beta-induced NO production and iNOS protein expression.
  • E2 reduced iNOS transcription, p65 DNA-binding capacity, and p65 nuclear translocation.

Conclusions:

  • Oestrogens and IL-1beta exhibit reciprocal antagonism in chondrocytes.
  • Oestrogens decrease cytokine-dependent NO production by transcriptionally inhibiting iNOS.
  • This inhibitory effect is mediated by selective inhibition of p65 DNA binding and nuclear translocation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...